FDA Inspection 1026395 — HQ, Inc.

HQ, Inc. — FEI 1038689

The FDA completed an inspection of HQ, Inc. on September 22, 2017 in Palmetto, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 8 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 22, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Compliance: Devices
Location
Palmetto, FL (United States)

Citations

IDCFRDescription
313021 CFR 820.100(a)Lack of or inadequate procedures
317221 CFR 820.198(c)Investigation of device failures
320121 CFR 820.40(a)Not approved or obsolete document retrieval
326621 CFR 820.86Acceptance status
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures
53721 CFR 820.70(a)Production processes
63021 CFR 803.17Lack of Written MDR Procedures